News and Information

Press Release

SEATTLE - Receptor Life Sciences (RLS), a leader in FDA-regulated cannabinoid medicine drug development using proprietary delivery technologies, today announced the formation of its inaugural Scientific Advisory Board (SAB).

Press Release

SEATTLE - Alexander W. Casdin, Founder, CEO, and Portfolio Manager of Reneo Capital Management LP, has been named to the Board of Directors of Receptor Holdings (RHI).

Press Release

SEATTLE - Receptor Life Sciences today announced the appointment of Orrin Devinsky, M.D., as the company’s Chief Medical Officer.

Press Release

SEATTLE – Receptor Holdings, Inc. and its wholly-owned subsidiary, Receptor Life Sciences, a biopharmaceutical company developing cannabinoid medicines featuring distinct pharmaceutical drug delivery technologies, today announced that it raised $29 million in a combined convertible debt and Series A round of financing.

News

Receptor Life Sciences, Inc. today announced that it has entered into a collaboration and license agreement with MannKind Corporation.